Otolaryngology Doctors in Kirkland, WA Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Dr. Kenneth D Faw, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 12333 Ne 130th Ln Ste 440, Kirkland, WA 98034 Phone: 425-899-3838    Fax: 425-899-3844

Mr. William Gregory Young Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste 440, Kirkland, WA 98034 Phone: 425-899-3838    Fax: 425-899-3844

John M Brockenbrough, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12303 Ne 130th Ln Ste 400, Kirkland, WA 98034 Phone: 425-899-4590    Fax: 425-899-4591

Ludwig A Allegra, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Carillon Point, Kirkland, WA 98033 Phone: 425-576-1700    Fax: 425-827-7725

Dr. Daniel James Liebertz, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5209 Lake Washington Blvd Ne, Ste 115, Kirkland, WA 98033 Phone: 425-822-0300    Fax: 425-822-4999

News Archive

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

IMS launches new Recommendations to manage postmenopausal vaginal atrophy

To mark World Menopause Day on 18th October 2010, the International Menopause Society (IMS) is launching new Recommendations for the management of postmenopausal vaginal atrophy, a distressing condition that will affect up to half of women after menopause.

Hospitals to get more bargaining clout for medical devices

The Wall Street Journal: "Hospitals lack leverage when negotiating prices for high-cost implants like defibrillators and replacement hips because individual doctors, rather than hospitals, typically select the products they use in their patients. Since these doctors often aren't hospital employees, they have little incentive to bargain-hunt.

Ipsen, Inspiration Biopharmaceuticals sell IB1001 hemophilia B product to Cangene

Inspiration Biopharmaceuticals and Ipsen today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation.

UMSOM receives landmark contract from NIAID for influenza research

Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine and Dean E. Albert Reece, MD, PhD, MBA, announced that CVD has been awarded a contract from the National Institute of Allergy and Infectious Diseases, with total funding up to more than $200 million over seven years if all contract options are exercised.

Read more Medical News

› Verified 8 days ago